Hostname: page-component-8448b6f56d-c47g7 Total loading time: 0 Render date: 2024-04-18T22:09:54.681Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmacokinetics of clozapine

Published online by Cambridge University Press:  03 January 2018

G. Swift
G. Swift*
Affiliation:
Department of Psychiatry, Mater Misericordiae Hospital, University College Dublin, 63 Eccles Street, Dublin 7, Republic of Ireland
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 175 , Issue 3 , September 1999 , pp. 288
Copyright
Copyright © 1999 The Royal College of Psychiatrists 

References

Buchanan, A. (1992) A two-year prospective study of treatment compliance in patients with schizophrenia. Psychological Medicine, 22, 787–797.Google Scholar
Cramer, J. A. (1991) Overview of methods to measure and enhance patient compliance. In Patient Compliance in Medical Practise and Clinical Trials (eds J. A. Cramer & I. A. Spiker). New York: Raven Press.Google Scholar
Falloon, I., Watt, D. C. & Shepherd, M. (1978) A comparative controlled trial of pimozide and fluphenazine decanoate in the continued treatment of schizophrenia. Psychological Medicine, 8, 59–70.Google Scholar
Kurz, M., Hummer, M., Kemmler, G., et al (1998) Long-term pharmacokinetics of clozapine. British Journal of Psychiatry 173, 341–344.CrossRefGoogle ScholarPubMed
Thorup, M. & Fog, R. (1977) Clozapine treatment of schizophrenic patients. Acta Psychiatrica Scandinavica, 55, 123–126.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.